Chambers, Mark S <br/><br/>
An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties.  [electronic resource] 

 -  Journal of medicinal chemistry  Nov 2004 
 - 5829-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm040863t  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Binding Sites<br/>Biological Availability<br/>Cognition--drug effects<br/>Dogs<br/>GABA-A Receptor Agonists<br/>Isoxazoles--adverse effects<br/>Maze Learning--drug effects<br/>Mice<br/>Nootropic Agents--adverse effects<br/>Patch-Clamp Techniques<br/>Protein Subunits<br/>Radioligand Assay<br/>Rats<br/>Receptors, GABA-A--metabolism<br/>Triazines--adverse effects